CEBP Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hawley, S. T.
Right arrow Articles by Vallejo, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hawley, S. T.
Right arrow Articles by Vallejo, B.
Cancer Epidemiology Biomarkers & Prevention Vol. 13, 314-319, February 2004
© 2004 American Association for Cancer Research


Short Communications

Prevalence of Colorectal Cancer Screening in a Large Medical Organization

Sarah T. Hawley1, Sally W. Vernon2, Bernard Levin3 and Beryl Vallejo4

1 Baylor College of Medicine, Department of Family and Community Medicine, Houston, Texas; 2 Center for Health Promotion and Prevention Research, University of Texas–Houston School of Public Health, Houston, Texas; 3 Division of Cancer Prevention, University of Texas M. D. Anderson Cancer Center, Houston, Texas; and 4 University of Texas–Houston School of Public Health, formerly of Kelsey Research Foundation, Houston, Texas

The primary objective of this study was to determine the prevalence of colorectal cancer (CRC) screening among eligible patients in a large medical practice. A secondary objective was to compare CRC screening rates obtained from medical records with physician self-reported CRC screening recommendation. We conducted a retrospective record review of 214 patients ages >= 50 years of a large multispecialty medical organization in Houston, Texas, for receipt of fecal occult blood test (FOBT), flexible sigmoidoscopy (SIG), and/or colonoscopy (COL). We estimated prevalence using two definitions: (a) FOBT in past year or SIG in past 5 years or COL in past 10 years; and (b) FOBT in past year and SIG in past 5 years or COL in past 10 years. Age, gender, race/ethnicity, family history, number of chronic conditions, and index visit were independent variables. Contingency table and logistic regression analysis were used to test for associations between outcomes and independent variables. Our study population was 48% male with a mean age of 63 years (range: 53–84 years). One-quarter of the records showed FOBT by 3-day kit (51 of 214) and 27% by digital rectal exam (57 of 214). SIG was recorded in 32% of records. Half (54%) of the records had documentation of CRC screening according to definition no. 1 and 19% according to definition no. 2. Screening rates from medical record review were lower than those derived from physician self-report. Our findings underscore the need for interventions to improve CRC screening in primary care settings.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. E. Lamerato, P. M. Marcus, G. Jacobsen, and C. C. Johnson
Recruitment in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial: the First Phase of Recruitment at Henry Ford Health System
Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 827 - 833.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. W. Vernon, J. A. Tiro, R. W. Vojvodic, S. Coan, P. M. Diamond, A. Greisinger, and M. E. Fernandez
Reliability and Validity of a Questionnaire to Measure Colorectal Cancer Screening Behaviors: Does Mode of Survey Administration Matter?
Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 758 - 767.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. P. Schenck, C. N. Klabunde, J. L. Warren, S. Peacock, W. W. Davis, S. T. Hawley, M. Pignone, and D. F. Ransohoff
Data Sources for Measuring Colorectal Endoscopy Use Among Medicare Enrollees
Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 2118 - 2127.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
J. J. Fenton, Y. Cai, N. S. Weiss, J. G. Elmore, R. E. Pardee, R. J. Reid, and L.-M. Baldwin
Delivery of Cancer Screening: How Important Is the Preventive Health Examination?
Arch Intern Med, March 26, 2007; 167(6): 580 - 585.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2004 by the American Association for Cancer Research.